| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.08M | $6.93M | - | |
| VP | 300.8K | $1.93M | - | |
| CFO | 295.3K | $900.7K | - | |
| Other | 189.4K | $1.22M | - | |
| Other | 100.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2018 | McCarthy Sean A.68 | President and CEO | Sale+OE | 19,578 | $29.43 | $576,141.38 | -80.8% | |
| Feb 28, 2018 | Humphrey Rachel | Chief Medical Officer | Sale+OE | 23,840 | $30.00 | $715,200.00 | -44.1% | |
| Feb 28, 2018 | Gluck Frederick W | Director | Sell | 3,819 | $30.00 | $114,570.00 | -1.3% | |
| Feb 1, 2018 | Ray Debanjan | Chief Financial Officer | Sell | 2,548 | $26.69 | $68,009.94 | -35.0% | |
| Jan 5, 2018 | Gluck Frederick W | Director | Sell | 10,000 | $25.01 | $250,078.00 | -3.3% | |
| Jan 5, 2018 | McCarthy Sean A.68 | President and CEO | Sale+OE | 6,526 | $25.01 | $163,215.26 | -58.4% | |
| Jan 2, 2018 | McCarthy Sean A.68 | President and CEO | Sale+OE | 13,052 | $21.04 | $274,614.08 | -73.8% | |
| Jan 2, 2018 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $21.11 | $52,775.00 | -25.5% | |
| Dec 26, 2017 | Gluck Frederick W | Director | Sell | 5,000 | $22.29 | $111,425.50 | -1.6% | |
| Dec 1, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $20.58 | $51,450.00 | -20.3% |